Search results for: sleep

ARP Year in Review: Updates in Advanced Practice, Epidemiology & Rehabilitation

Catherine Kolonko | November 12, 2025

Three experts discussed recent notable research of interest to rheumatology professionals across a range of topics.

Differentiating POTS from Other Conditions

Mary Beth Nierengarten | November 6, 2025

At a ACR Convergence 2025 session, two experts discussed POTS, the importance of considering dysautonomia when making a differential diagnosis & an interdisciplinary approach to treatment.

JIA: The Transition to Adult Care

Ruth Jessen Hickman, MD | November 5, 2025

Experts addressed considerations for how to aid patients with juvenile idiopathic arthritis (JIA) in their transition to adult care, specifically highlighting clinical pearls for those with pediatric uveitis and TMJ arthritis.

Updates on Fibromyalgia & the Quest to Alleviate Pain

Jason Liebowitz, MD, FACR | October 29, 2025

ACR Convergence 2025 speakers reviewed new fibromyalgia insights, from the first new drug approval since 2009 to nociplastic pain concepts & cognitive behavioral therapy.

The 2025 ARP President’s & Merit Awards

Patrice Fusillo | October 25, 2025

Meet the 2025 ARP President’s & Merit Award recipients honored for their significant contributions to rheumatology research, education & patient care.

A New Treatment for Fibromyalgia?

Michele B. Kaufman, PharmD, BCGP | September 11, 2025

The FDA has approved a new drug application for TNX-102 SL (Tonmya), a tablet with 2.8 mg of cyclobenzaprine HCl, after two clinical trials demonstrated the safety and effectiveness of the treatment in adults with fibromyalgia.

Rheuminations: Why Deliberate Practice & Relentless Curiosity Matter

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS | September 5, 2025

What does it take to become a master in rheumatology? Explore how deliberate practice, relentless curiosity & profound humility are key to true expertise.

How the Experts Treat Sjögren’s Disease

Samantha C. Shapiro, MD | August 26, 2025

With no FDA-approved drugs for Sjögren’s disease, experts share strategies for managing fatigue, arthritis, dryness, and systemic issues.

Encourage Physical Activity During Rheumatic Disease Awareness Month

Vanessa Caceres | August 25, 2025

This year’s Rheumatic Disease Awareness Month encourages rheumatology professionals to collaborate with patients on physical activity routines that benefit their health.

The Rheumatic Dangers of Wildfire Smoke

Deborah Levenson | August 7, 2025

A recent study in A&R identifies an association between air pollutants, including fire smoke particulate matter, & both rheumatoid arthritis (RA) & RA-associated interstitial lung disease.